Anticonvulsant activity of methanol stem bark extract of Boswellia dalzielii Hutch. (Burseraceae) in mice and chicks
Abstract
Background: Boswellia dalzielii is a widely used medicinal plant in African traditional medicine. The efficacy of its stem bark extract in management of convulsions is well acclaimed among communities of Northern Nigeria.
Objective: To evaluate the anticonvulsant potentials of methanol stem bark extract of Boswellia dalzielii in mice and chicks.
Methodology: Phytochemical screening, elemental analysis and acute toxicity studies was carried out. The extract was evaluated for anticonvulsant activity against electrically-induced seizures in chicks and against pentylenetetrazole, strychnine, picrotoxin and 4-aminopyridine-induced seizures in mice at doses of 20, 40 and 80 mg/kg.
Results: The intraperitoneal LD50 was estimated to be 280 and 570 mg/kg in mice and chicks respectively. The extract at 20 mg/kg provided 40% protection and significantly (p<0.05) increased the mean onset of seizure in MEST. A dose-dependent and significant (p<0.05) increase in the mean onsets of pentylenetetrazole and strychnine-induced seizures were produced by the extract at 80 mg/kg. Similarly, a dose-dependent and significant increase (p<0.05 and p<0.01) in latency to picrotoxin-induced convulsions was observed at 40 and 80 mg/kg respectively.
Conclusion: These findings suggests the methanol stem bark extract of Boswellia dalzielii possesses anticonvulsant activities and thus supports the ethnomedical rationale for its use against convulsions.
Keywords: Anticonvulsant, Boswellia dalzielii, Epilepsy, Pentylenetetrazole, Picrotoxin
References
Association of Official Analytical Chemist (AOAC) (1995). Official Methods of Analysis, 15th ed, Washington D.C.
Banerjee PN, Filippi D, Hauser WA (2009). The descriptive epidemiology of epilepsy – a review. Epilepsy Res. 85: 31-45.
Browning R (1992). The electroshock model, neuronal network and antiepileptic drugs In: Drugs for Control of Epilepsy: Actions on Neuronal Networks in Seizure Disorders. Faingold, CL and Fromm GH (Eds), CRC Press, Boca Raton, FL, pp 195-211.
Bum EN, Schmutz M, Meyer C, Rakotonirina A, Bopelet M, Portet C, Jeker A, Rakotonirina SV, Olpe HR and Herrling P (2001). Anticonvulsant properties of the methanolic extract of Cyperus articulatus (cyperaceae). J. Ethnopharmacol. 76: 145-150.
Burkill HM (1985). Useful plants of West Tropical Africa. Vol.1, Royal Botanical Gardens, Kew.
Cockburn F, Brown JK, Belton NR and Forfar JO (1973). Neonatal convulsions associated with primary disturbance of calcium, phosphorus, and magnesium metabolism. Arch. Dis. Childhood, 48: 99–108.
Corbett JR, Wright K and Baillie AC (1984). The Biochemical mode of Action of pesticides, second edition, Academic press, London and New York.
DeLorenzo RJ, Raza M, Saheen F, Choudhary MI, Suria A, Atta-ur-Rahman and Sombati S (2001). Anticonvulsant Activities of the FS-1 Subfraction isolated from Roots of Delphinium denadatum. Phytotherapy Res. 15: 426-430.
Ibrahim JA, Muazzam I, Jegede IA, Kunle OF and Okogun JI (2007). Ethnomedicinal plants and methods used by Gwandara tribe of Sabo Wuse in Niger state, Nigeria to treat mental illness. Afr. J. Trad. Complement. Altern. Med. 4: 211 – 218.
Johannessen Landmark C, Patsalos PN (2010). Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Rev. Neurother. 10: 119-140.
Kavvadias D, Sand P, Youdim KA, Qaiser MZ, Rice-Evans C, Baur R, Siegel E, Rausch WF, Riederer P and Schreier P (2004). The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties traverses the blood brain barrier and exhibit anticonvulsant effects. Br. J. Pharmacol. 142: 811-820.
Kumar S, Reecha M, Gundeep B, Anupam J and Anupam S (2012). Plants and Plant Products with Potential Anticonvulsant Activity – A Review. Pharmacog. Comm. 2: 3-99.
Leonard BE (2000). Fundamentals of Psychopharmacology, 2nd Edition, Chichester: John Wiley and Sons. United Kingdom.
Lorke D (1983). A new approach to practical acute toxicity testing. Arch. Toxicol. 54: 275-287.
Loscher W (2002). Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol. Sci. 23: 113–118.
Magaji MG, Yaro AH, Musa AM, Anuka JA, Abdu-Aguye I and Hussaini IM (2013). Anticonvulsant activity of butanol fraction of methanol root bark extract of Securinega virosa Roxb (ex Willd) Baill. in laboratory animals. J. Medicinal Plants Res. 7: 2128-2135.
Malami S, Kyari H, Danjuma NM, Ya’u J and Hussaini IM (2016). Anticonvulsant properties of methanol leaf extract of Laggera aurita Linn. F. (Asteraceae) in laboratory animals. J. Ethnopharmacol. 191: 301-306.
McNamara JO (2006). Pharmacotherapy of the epilepsies. In: Goodman and Gilman’s The Pharmacological Basis of Therapeutics 11th ed. Brunton LL, Lazo JS and Parker KL (Eds) McGraw-Hill Medical Publishing Division, New York, pp 501–526.
Miller GD, Jarvis JK and McBean LD (2001). The importance of meeting calcium needs with foods. J. Am. Coll. Nutr. 20: 168-185.
Nazifi AB, Saidi O and Ismail HF (2015). Evaluation of anticonvulsant effects of methanolic extract of Olax subscorpioidea Oliv. leaves in chicks and mice. J. Pharm. Biores. 12: 165-171.
Newman DJ and Cragg GM (2012). Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75: 311-335.
Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW and Newton CR (2010). Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia. 51: 883-890.
Nicoll RA (2001). Introduction to the Pharmacology of CNS drugs. In: Basic and Clinical Pharmacology, 8th ed. Katzung BG (Ed) Lange Medical Books/McGraw-Hill. New York, USA. pp. 351-363.
Porter RJ, Cereghino JJ and Gladding GD (1984). Antiepileptic drug development program. Cleve Clin. Quart. 51: 293-305.
Quintans Jr. LJ, Almeida JRGS, Lima JT, Nunes XP, Siqueira JS, Oliveira LEG, Almeida RN, Athayde-Filho PF and Barbosa-Filho JM (2008). Plants with anticonvulsant properties - a review. Braz. J. Pharmacog. 18: 798-819.
Raza M, Shaheen F, Choudhary MI, Suria A, Atta-ur-Rahman, Sombati S and Deloranzo RJ (2001). Anticonvulsant activities of the FS-1 sub fraction isolated from roots of Delphinium denudatum. Phytother. Res. 15: 426-430.
Roberton NRC and Smith MA (1975). Early neonatal hypocalcaemia. Arch. Dis. Childhood. 50: 604-609.
Sayin U, Cengiz S and Altug T (1993). Vigabatrin as an anticonvulsant against pentylenetetrazole seizures. Pharmacol. Res. 28: 325-331.
Swinyard EA (1969). Laboratory evaluation of antiepileptic drugs: Review of laboratory methods. Epilepsia. 10: 107-119.
Swinyard EA and Kupferberg HJ (1985). Antiepileptic drugs: detection, quantification and evaluation. Fed. Proc. 44: 39-43.
Swinyard EA, Woodhead JH, White HS and Franklin MR (1989). General Principles: Experimental selection, quantification, and evaluation of anticonvulsants. In: Antiepileptic Drugs 3rd ed. Levy RH, Mattson B, Melrum JK and Dreifuss FE (Eds). Raven Press. New York. pp 154-163.
Vogel GH (2008). Psychotropic and neurotropic activity. In: Drug discovery and Evaluation: Pharmacological Assays 3rd ed. Vogel GH (Ed). Springer-Verlag Berlin Heidelberg, New York, pp 566-874.
Vongtau HO, Abbah J, Ngazal IE, Kunle OF, Chindo BA, Ostapa PB and Gamaniel KS (2004). Antinociceptive and anti-inflammatory activities of the methanolic extract of Pinanari polyandra stem bark in rats and mice. J. Ethnopharmacol. 90: 115-121.
Wagner H and Bladt S (1996). Plant Drug Analysis. A thin layer Chromatography Atlas 2nd ed. Springer-Verlag Berlin Heidelberg New York.
White HS, Wolf HH, Woodhead JH and Kupferberg HJ (1998). The national institute of health anticonvulsant drug development program: screening for efficacy. In: Antiepileptic drug development: Advances in Neurology. French J, Leppik IE and Ditcher MA (Eds). Lippincott-Raven Publishers, Philadelphia, pp 29-39.
WHO (2017). Epilepsy. http://www.who.int/mediacentre/factsheets/fs999/en/ (Accessed 16 Feb., 2017)
Wickenden AD (2002). Potassium channels as antiepileptic drug targets. Neuropharmacol. 43: 1055-1060.
Yamaguchi SI and Rogawski MA (1992). Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res. 11: 9-16.
Yemitan OK, and Adeyemi OO (2013). Antiepileptogenic and anticonvulsant actions of Dalbergia saxatilis (Hook, F.) in sub-toxic chemical kindling and toxic convulsant models. Eur. J. Med. Plants. 3: 288-296.
Yaro AH, Musa AM, Magaji MG and Nazifi AB (2015). Anticonvulsant potentials of methanol leaf extract of Cissus cornifolia Planch (Vitaceae) in mice and chicks. Int. J. Herbs Pharmacol. Res. 4: 25-32.
Full Text: PDF
Refbacks
- There are currently no refbacks.